ImmuCell Corporation ICCC
10.75 USD +0.55 (+5.44%)
Regular-session close
10.75 0.00 0.00%
After hours · Nov 13, 4:00 PM ET
10.50 Day range 10.81
4.56 52-week range 11.72
- YTD
- +74.80%
- 1 year
- +77.69%
News
seekingalpha.com ImmuCell Corporation (ICCC) Q3 2026 Earnings Call Transcript ImmuCell Corporation (ICCC) Q3 2026 Earnings Call Transcript
marketbeat.com ImmuCell Q3 Earnings Call Highlights ImmuCell NASDAQ: ICCC reported a 46% increase in third-quarter product sales and returned to profitability as improved manufacturing output and stronger demand supported its First Defense calf-health…
benzinga.com ImmuCell Q3 EPS $0.10 Up From $(0.02) YoY, Sales $8.040M Up From $5.506M YoY ImmuCell (NASDAQ:ICCC) reported quarterly earnings of $0.10 per share. This is a 600 percent increase over losses of $(0.02) per share from the same period last year. The company reported $8.040…
globenewswire.com ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2026 PORTLAND, Maine, Nov. 12, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health biologics company that develops, manufactures and markets…